Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

1.850 -0.050 (-2.63%)
Streaming Delayed Price Updated: 10:56 AM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,850
Open 1.860
Bid (Size) 1.820 (10)
Ask (Size) 1.880 (1)
Prev. Close 1.900
Today's Range 1.800 - 1.885
52wk Range 1.000 - 3.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6
Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology. 
Via Stocktwits
Exposures Product Safety
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety

Performance

YTD
+31.2%
+31.2%
1 Month
+36.0%
+36.0%
3 Month
-12.7%
-12.7%
6 Month
+21.7%
+21.7%
1 Year
-17.4%
-17.4%

More News

Read More
EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing
Via Benzinga
Exposures Product Safety
InvestorNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (Nasdaq: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout
Via Investor Brand Network
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
Via Investor Brand Network
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%
Via Benzinga
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property Product Safety
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch
Via Benzinga
Exposures Product Safety
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Which stocks are moving after the closing bell on Wednesday?
Via Chartmill
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
Via Benzinga
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
Via FinancialNewsMedia
Topics Cannabis Death
Exposures Cannabis Death
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites
Via Benzinga
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market
Via Benzinga
Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), to Present at NobleCon20
Via Investor Brand Network
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
Via NewMediaWire

Frequently Asked Questions

Is Intelligent Bio Solutions Inc. - Common Stock publicly traded?
Yes, Intelligent Bio Solutions Inc. - Common Stock is publicly traded.
What exchange does Intelligent Bio Solutions Inc. - Common Stock trade on?
Intelligent Bio Solutions Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intelligent Bio Solutions Inc. - Common Stock?
The ticker symbol for Intelligent Bio Solutions Inc. - Common Stock is INBS on the Nasdaq Stock Market
What is the current price of Intelligent Bio Solutions Inc. - Common Stock?
The current price of Intelligent Bio Solutions Inc. - Common Stock is 1.850
When was Intelligent Bio Solutions Inc. - Common Stock last traded?
The last trade of Intelligent Bio Solutions Inc. - Common Stock was at 06/13/25 10:56 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.